CI

At a glance

ClinicalIndex Comparison Record
Phase 4Completed· 13 enrolled
Drug / intervention
OASIS Wound Matrixdevice
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT00570141
NCT00570141Phase 4Completed
CompareCT.gov

Case Study Documentation of Subjects With Either Diabetic Foot Ulcers or Venous Stasis Ulcers Being Treated With OASIS

Healthpoint·interventional·Posted Dec 10, 2007·Updated Jun 9, 2011

In Brief

A Phase 4 clinical trial evaluating OASIS Wound Matrix for Diabetic Foot Ulcers (DFU) and Venous Stasis Ulcers (VSU). Completed, enrolled 13 participants across 3 sites.

Detailed Summary

OASIS Wound Matrix (Oasis) will be applied to wounds, with sequential biopsy of healing wounds to explore the mechanism of action.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsDiabetic Foot Ulcers (DFU), Venous Stasis Ulcers (VSU)
CountriesUnited States
Collaborators--

Timeline

Phase 4CompletedFinished
20082009201020112012201320142015201620172018201920202021202220232024202520262027
First PostedDec 10, 2007
Enrollment StartOct 1, 2007
Primary CompletionApr 1, 2009
Study CompletionApr 1, 2010
TodayJul 2, 2026
Enrollment to primary: 1.5 yearsPosted 18.6 years ago

Interventions

OASIS Wound Matrixdevice

OASIS (an acellular biomaterial that supports tissue repair with a scaffold-like matrix having a natural structure and composition).